Skip to main content
. Author manuscript; available in PMC: 2009 Oct 5.
Published in final edited form as: Platelets. 2008 Sep;19(6):415–427. doi: 10.1080/09537100802220468

Figure 4. The inhibitory effect of a LPA1/3 agonist (compound 4) on platelets is pre-incubation time dependent.

Figure 4

A concentration of 0.2 µM compound 4 that itself did not induce shape change was incubated for different time periods before exposure to acyl-LPA 16:0 (20nM).